China Shineway Pharmaceutical Group Limited
CSWYF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6,140 | $858 | – | $738 |
| Short-Term Investments | $350 | $0 | – | $0 |
| Receivables | $1,202 | $179 | – | $167 |
| Inventory | $813 | $114 | – | $110 |
| Other Curr. Assets | $93 | $14 | – | $9 |
| Total Curr. Assets | $8,599 | $1,165 | – | $1,024 |
| Property Plant & Equip (Net) | $1,219 | $167 | – | $171 |
| Goodwill | $166 | $23 | – | $23 |
| Intangibles | $23 | $4 | – | $28 |
| Long-Term Investments | $0 | -$12 | – | $0 |
| Tax Assets | $34 | $12 | – | $2 |
| Other NC Assets | $0 | -$11 | – | -$23 |
| Total NC Assets | $1,443 | $195 | – | $201 |
| Other Assets | $0 | $0 | – | $0 |
| Total Assets | $10,042 | $1,360 | – | $1,225 |
| Liabilities | – | – | – | – |
| Payables | $403 | $63 | – | $387 |
| Short-Term Debt | $338 | $54 | – | $304 |
| Tax Payable | $84 | $9 | – | $13 |
| Deferred Revenue | $0 | $17 | – | $11 |
| Other Curr. Liab. | $1,624 | $191 | – | -$418 |
| Total Curr. Liab. | $2,450 | $335 | – | $286 |
| LT Debt | $8 | $2 | – | $1 |
| Deferred Rev, NC | $82 | $0 | – | $22 |
| Deferred Tax Liab, NC | $35 | $0 | – | $3 |
| Other NC Liab. | $0 | $14 | – | -$160 |
| Total NC Liab. | $125 | $16 | – | $26 |
| Other Liabilities | $0 | $0 | – | $0 |
| Cap. Leases | $17 | $10 | – | $4 |
| Total Liabilities | $2,575 | $351 | – | $311 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | – | $0 |
| Common Stock | $88 | $12 | – | $12 |
| Retained Earnings | $6,726 | $924 | – | $836 |
| AOCI | $0 | -$68 | – | $87 |
| Other Equity | $653 | $142 | – | -$22 |
| Total Equity | $7,467 | $1,009 | – | $914 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | – | $0 |
| Total Liab. & Tot. Equity | $10,042 | $1,360 | – | $1,225 |
| Net Debt | -$5,794 | -$802 | $0 | -$434 |